
The Viral Immunity and Immunopathology Laboratory at @Hudson_Research @CiiiD_Research Host-directed therapies for #influenza and pulmonary inflammation
Melbourne, Australia
Joined March 2023
- Tweets45
- Following129
- Followers109
- Likes174
🫁 It’s the epithelium, not myeloid cells.
Epithelial NLRP3 drives lung injury and fibrosis via IL‑18 and pro‑fibrotic neutrophils.
doi.org/10.1186/s12989-026-0…
Although there are no effective drugs for severe influenza, a breakthrough led by @Tate_Lab in collaboration with Associate Professor Ashley Mansell, led to innovative treatments that target the body rather than the virus itself to limit inflammation and save lives.
Read more in NHMRC’s 10 of the Best 17th Edition now on our website: ow.ly/yTS850YJiFC
Excited to share our new work in @MucosalImmunol on preventing the #1 killer after flu: secondary bacterial pneumonia
mucosalimmunology.org/articl…
Our latest paper on influenza and gasdermin E
@CiiiD_Hudson
@Hudson_Research
nature.com/articles/s41419-0…
Tate_Lab retweeted
Exciting news! The AVS12 Meeting Report is now published in the @ASMicrobiology Journal of Virology 🎉
AVS prides itself on supporting all voices in virology through career development, Indigenous engagement, collaboration, and recognition of excellence.
journals.asm.org/doi/10.1128…
Tate_Lab retweeted
🚨 Registrations for #AVS12 are still open! 🚨
📅 Dec 2-5 | 📍 RACV Goldfields, Creswick, VIC
Join us for an unforgettable event!
🔗 Register now: avs2024.org
Tate_Lab retweeted
Taking AIM at Influenza: The Role of the AIM2 Inflammasome
✍️by Xu & Tate
👉mdpi.com/1999-4915/16/10/153…
#influenza #sensing #immunology
Tate_Lab retweeted
Options for the control of influenza XII Conference #optionsxii2024 Brisbane
Tate_Lab retweeted
Join us this December for AVS2024! Early Bird Registration & Abstract deadline is Friday 9th August
Stay Posted here: avs2024.org
Tate_Lab retweeted
When patients with severe flu are admitted to hospital there are no effective drugs available to reduce the response to the virus. Our researchers are focusing on finding treatments to help these patients
2024 flu season guide: bit.ly/4dWolB5
@Tate_Lab @CiiiD_Research
Tate_Lab retweeted
Thrilled to be receiving this award!
Massive thanks to the @Lungfoundation and @Tate_Lab for all the support!
#TSANZRS2024
Tate_Lab retweeted
Lung Foundation Australia's Hope Research Fund grants for 2024 have been awarded! We would like to offer our congratulations to the early and mid-career PHDs and fellowships awardees 👏
Tate_Lab retweeted
We are pleased to announce our April #ACDS Seminar will feature @Sarah_Rosli_ @Hudson_Research & Dr Robson Kriiger Loterio @BurnetInstitute! 👏
Join us on Wed 3rd April (11am AEDT on Zoom) to hear how GSDME alters #influenza severity 🫁 and how Coxiella stops host #celldeath! 🦠
Tate_Lab retweeted
Save the date for AVS 2024
2nd– 5th December
RACV Goldfields, Creswick, VIC
Stay Posted here: avs2024.org/
Tate_Lab retweeted
Congratulations to @DrEmilyGulliver from @Forster_Lab on winning best ECR talk and @Sarah_Rosli_ from @Tate_Lab for winning best student poster at #lorneiandi! What a great meeting which showcased so much of the exciting research ongoing here at CiiiD & @Hudson_Research ! 👏
Our latest study is online - a novel host-directed therapy for influenza.
@CiiiD_Hudson @Hudson_Research academic.oup.com/jid/article…
Tate_Lab retweeted
A/Prof Michelle Tate, PhD student Sarah Rosli & their team have identified a protein, Gasdermin D, in lung epithelial cells which promotes hyper-inflammation & cell death in severe cases of #Influenza. 🫁 Read more: bit.ly/3uRQXZY
Congratulations @kristian_barry7!
Hendra virus C-protein activates the NLRP3 inflammasome.
@CiiiD_Hudson @Hudson_Research
doi.org/10.1186/s12950-023-0…
Our latest paper is out today!Congratulations @Sarah_Rosli_
@CiiiD_Hudson @Hudson_Research doi.org/10.1038/s41419-023-0…























